medical device

13 articles
BenzingaBenzinga··Prnewswire

Aethlon Medical Advances Hemopurifier Trial to Final Cohort After Safety Clearance

Aethlon Medical's Hemopurifier device advances to final clinical trial phase following positive safety review with no adverse events reported.
AEMDclinical trialoncology
BenzingaBenzinga··Lensar, Inc.

LENSAR Terminates Alcon Merger After FTC Opposition, Retains $10M Deposit

LENSAR ends merger with Alcon due to FTC regulatory hurdles. Company retains $10M deposit, refocuses on independent growth strategy for robotic cataract laser system.
LNSRregulatory approvalcataract surgery
GlobeNewswire Inc.GlobeNewswire Inc.··Senseonics Holdings, Inc.

Senseonics' Eversense 365 Proves Durable: Real-World Data Shows 94% Wear Rate, Strong Glucose Control

Senseonics reports real-world data from 5,059 Eversense 365 CGM users showing 93.8% wear time and strong glucose control metrics over one year.
SENSmedical devicediabetes management
GlobeNewswire Inc.GlobeNewswire Inc.··Picard Medical, Inc.

SynCardia's Artificial Heart Technology Takes Center Stage on FOX Business

Picard Medical's SynCardia Systems showcases its Total Artificial Heart technology on FOX Business, highlighting over 2,100 implants worldwide.
PMIFDA approvalheart failure
GlobeNewswire Inc.GlobeNewswire Inc.··Beyond Air, Inc.

Beyond Air to Present Nitric Oxide Pipeline at Roth Conference

Beyond Air ($XAIR) will present at the 38th Annual Roth Conference in March, showcasing its nitric oxide therapy platform for respiratory and oncology applications.
XAIRbiopharmaceuticalmedical device
BenzingaBenzinga··Prnewswire

IceCure Medical to Release 2025 Results March 17, Signaling Year-End Performance Review

IceCure Medical will report 2025 full-year results March 17, 2026, before market open, with a conference call at 11:00 a.m. EDT.
ICCMfinancial resultsearnings announcement
The Motley FoolThe Motley Fool··Josh Kohn-Lindquist

TransMedics Soars 104% as Organ Transplant Monopoly Justifies Premium Valuation

TransMedics surges 104% on organ transplant dominance and 32% growth, but 56x forward earnings premium and 25% short interest raise sustainability questions for 2026.
TMDXvaluationmarket share
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Catheter Precision's LockeT Device Gains Platform at Major 2026 Medical Conference

Catheter Precision ($VTAK) will showcase its FDA-approved LockeT suture retention device at ISLAA 2026, demonstrating cost-saving wound closure technology to electrophysiology fellows.
VTAKFDA approvalmedical device
BenzingaBenzinga··Prnewswire

IceCure's Cryoablation Wins Independent Validation for Breast Fibroadenomas

IceCure's ProSense cryoablation achieved 92.9% volume reduction in independent breast fibroadenoma study, validating technology for a 63,000-patient annual U.S. market.
ICCMmedical deviceminimally invasive surgery
The Motley FoolThe Motley Fool··Prosper Junior Bakiny

TransMedics Expands Organ Preservation Technology Amid Fleet Investment

TransMedics expands organ preservation technology platform and invests in dedicated aircraft transportation to improve transplant logistics and organ utilization rates.
TMDXregulatory approvalhealthcare innovation
The Motley FoolThe Motley Fool··Eric Volkman

Integer Holdings Gains on Strong Q4 Results and Analyst Upgrades

Integer Holdings stock rose 2% after Q4 earnings beat expectations and analyst upgrades. Multiple firms raised price targets, citing strong sales growth and improved profit margins.
WFCWFCpAWFCpCWFCpDWFCpL+7analyst upgradeearnings beat
GlobeNewswire Inc.GlobeNewswire Inc.··Na

ReWalk Exoskeleton Gains Aetna Coverage, Now Accessible Through Three Major Medicare Advantage Plans

Aetna approves Medicare Advantage coverage for ReWalk exoskeleton, expanding access to three major insurers serving 16 million beneficiaries and marking progress for wearable robotic technology reimbursement.
UNHLFWDHUMmedical deviceReWalk Personal Exoskeleton
BenzingaBenzinga··Vandana Singh

Medtronic Gains FDA Clearance for Advanced Spine Surgery Navigation System

Medtronic received FDA clearance for its Stealth AXiS spine surgery navigation system with real-time tracking technology, reducing need for intraoperative imaging and radiation exposure during procedures.
MDTFDA clearancemedical device